Risk minimization measures
Risk minimization measures
| Scientific Name | Brand name | Approval Date | Last Update | Details |
|---|---|---|---|---|
| Ofatumumab | Arzerra | View | ||
| Carvedilol | Riacavilol | View | ||
| Panitumumab | Vectibix | View | ||
| Diclofenac Sodium | Rofenac | View | ||
| Belimumab | Benlysta | View | ||
| Diclofenac Sodium | Epifenac | View | ||
| Isotretinoin | Roaccutane | View | ||
| Tenofovir | Viread | View | ||
| Vemurafenib | Zelboraf | View | ||
| Filgrastim | Neupogen | View |